IDO1 and neoplasm: IDO1 metabolism can deplete the tryptophan from the tumor microenvironment, leading to the impairment of T-cells activation, thereby achieving immunosuppression of the tumor microenvironment and escaping attack by the host immune system (Terness et al., 2002).